                         SEQUENCE LISTING

<110>  INSERM
 
<120>  NEW METHOD TO EVALUATE CANCER PROGNOSIS

<130>  BIO20143 LACOMBE

<160>  7     

<170>  PatentIn version 3.3

<210>  1
<211>  187
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Gly Gly Leu Phe Trp Arg Ser Ala Leu Arg Gly Leu Arg Cys Gly 
1               5                   10                  15      


Pro Arg Ala Pro Gly Pro Ser Leu Leu Val Arg His Gly Ser Gly Gly 
            20                  25                  30          


Pro Ser Trp Thr Arg Glu Arg Thr Leu Val Ala Val Lys Pro Asp Gly 
        35                  40                  45              


Val Gln Arg Arg Leu Val Gly Asp Val Ile Gln Arg Phe Glu Arg Arg 
    50                  55                  60                  


Gly Phe Thr Leu Val Gly Met Lys Met Leu Gln Ala Pro Glu Ser Val 
65                  70                  75                  80  


Leu Ala Glu His Tyr Gln Asp Leu Arg Arg Lys Pro Phe Tyr Pro Ala 
                85                  90                  95      


Leu Ile Arg Tyr Met Ser Ser Gly Pro Val Val Ala Met Val Trp Glu 
            100                 105                 110         


Gly Tyr Asn Val Val Arg Ala Ser Arg Ala Met Ile Gly His Thr Asp 
        115                 120                 125             


Ser Ala Glu Ala Ala Pro Gly Thr Ile Arg Gly Asp Phe Ser Val His 
    130                 135                 140                 


Ile Ser Arg Asn Val Ile His Ala Ser Asp Ser Val Glu Gly Ala Gln 
145                 150                 155                 160 


Arg Glu Ile Gln Leu Trp Phe Gln Ser Ser Glu Leu Val Ser Trp Ala 
                165                 170                 175     


Asp Gly Gly Gln His Ser Ser Ile His Pro Ala 
            180                 185         


<210>  2
<211>  879
<212>  DNA
<213>  Homo sapiens

<400>  2
ggccgggcgt catgggcggc ctcttctggc gctccgcgct gcgggggctg cgctgcggcc     60

cgcgggcccc gggcccgagc ctgctagtgc gccacggctc gggagggccc tcctggaccc    120

gggagcggac cctggtggcg gtgaagcccg atggcgtgca acggcggctc gttggggacg    180

tgatccagcg ctttgagagg cggggcttca cgctggtggg gatgaagatg ctgcaggcac    240

cagagagcgt ccttgccgag cactaccagg acctgcggag gaagcccttc taccctgccc    300

tcatccgcta catgagctct gggcctgtgg tggccatggt ctgggaaggg tacaatgtcg    360

tccgcgcctc aagggccatg attggacaca ccgactcggc tgaggctgcc ccaggaacca    420

taaggggtga cttcagcgtc cacatcagca ggaatgtcat ccacgccagc gactccgtgg    480

agggggccca gcgggagatc cagctgtggt tccagagcag tgagctggtg agctgggcag    540

acgggggcca gcacagcagc atccacccag cctgaggctc aagctgccct taccacccca    600

tcccccacgc aggaccaact acctccgtca gcaagaaccc aagcccacat ccaaacctgc    660

ctgtcccaaa ccacttactt ccctgttcac ctctgcccca ccccagccca gaggagtttg    720

agccaccaac ttcagtgcct ttctgtaccc caagccagca caagattgga ccaatccttt    780

ttgcaccaaa gtgccggaca acctttgtgg tggggggggg tcttcacatt atcataacct    840

ctcctctaaa ggggaggcat taaaattcac tgtgcccag                           879


<210>  3
<211>  19
<212>  RNA
<213>  Artificial

<220>
<223>  Si1 targetting NME1

<400>  3
ggcuguagga aaucuaguu                                                  19


<210>  4
<211>  19
<212>  RNA
<213>  Artificial

<220>
<223>  Si2 targetting NME1

<400>  4
ggauuccgcc uuguugguc                                                  19


<210>  5
<211>  19
<212>  RNA
<213>  Artificial

<220>
<223>  Si1 targetting NME4

<400>  5
agcacaagau uggaccaau                                                  19


<210>  6
<211>  19
<212>  RNA
<213>  Artificial

<220>
<223>  Si2 targetting NME4

<400>  6
gcaagaaccc aagcccaca                                                  19


<210>  7
<211>  19
<212>  RNA
<213>  Artificial

<220>
<223>  Si1 CTL

<400>  7
ggcuguagaa gcuauaguu                                                  19


